BDR in pact to make Gilead drug for Cipla

-
In late May, BDR had sought the approval of India’s drug regulator to make and sell remdesivir in India without entering into an arrangement with Gilead. The Mumbai-based company has now signed a contract to make the drug for Cipla, which is one of the licensed companies.

from Stocks-Markets-Economic Times https://ift.tt/2yQY8oJ

Comments

Post a Comment

Popular posts from this blog

SBI to meet RBI brass on Aircel insolvency

-
Image
The RBI’s opposition to ARCs becoming resolution applicants (RA) could scuttle not just the Aircel plan but that of others such as Reliance Communications (RCom) as well. This would hurt state-run banks such as SBI, since they are the biggest lenders to companies that ARCs are looking to acquire in insolvency cases. from Stocks-Markets-Economic Times https://ift.tt/3joZLeO
Read more